100th episode - FemTech, BatteryTech and Dementia tech special

It’s our 100th episode! We thought this episode we’d pick three tech areas that are gaining in traction – do you agree with our choices? What other technologies are the ones to watch?#FemTech - Stasa Stankovic – talks to us about her goal to crack the code on reproductive genomics. Stasa talks about how #FemTech as a term often remains taboo, and how it was only in 1993 that women started to be included in female clinical trials. We need government, investment and funding, and research and innovation, to increase awareness and interventions around infertility, contraception, menopause, and broader women’s health. Who do you know in the #FemTech space? Faye referred to two of the recent impulse alumni - Melis Eda Ekinci, Lorna MacLean#BatteryTech - Dr Simon Engelke, Founder and Chair of Battery Associates joins to talk about the battery industry and the extensive range of batteries not only available but in development. The industry is still driven greatly by cost, but niche applications offer more room for novel improvements which may change future trends for the larger industries. We have some great showcase companies here in Cambridge in the #Battery space – Nyobolt, Prof Clare Grey, Sai Shivareddy, Ismail Sami, Molyon, Echion Technologies.#Dementia #Alzheimer #Technology - Andrew Kadis of Cambridge Vision Technology talks through how Alzheimer’s is the leading cause of death with one in three people not even being aware that they have it. Not only does Andrew share some huge statistics, but he also demonstrates the economic impact of not identifying Alzheimer’s early enough. Andrew shares their focus on biomarkers in the eye, iterating a business plan, and being part of future policy.And having put the overview together, we’ve just realised that our guests, and many of the companies mentioned in the episode are all previous #21toWatch or Trinity Bradfield Prize winners!Produced by Cambridge TV Hosted on Acast. See acast.com/privacy for more information.

There are no comments yet.

Please log in to write the first comment.